Less than two-thirds of eligible 30- to 65-year-old women are up to date with cervical cancer screening, and Pap completion rates have decreased over time.....
RBC Capital Markets analyst Randall Stanicky sees lots of reasons Allergan should pursue a breakup. A women’s health sale that could bring in billions is just one of them.
Teva earlier this week inked a pact to sell off one of its women’s health products—and now it’s closing in on a deal to divest that business’s assets outside the U.S.
“Why is ‘the pill’ called ‘the pill?’” comedic actress Vanessa Bayer asks in one of the birth control awareness videos in Allergan's newest digital campaign.